Last reviewed · How we verify
rectal swab
At a glance
| Generic name | rectal swab |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma (PHASE2)
- Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
- Active Surveillance Cultures for Multidrug Resistant Gram-Negative Organisms at an Acute Care Hospital
- Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T (PHASE2)
- Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma (PHASE2)
- Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients
- Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance
- The APS Phenotyping Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- rectal swab CI brief — competitive landscape report
- rectal swab updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI